Homocysteine and vascular disease in diabetes: a double hit? (Q36273292)

13 August 2017

1 reference

title

Homocysteine and vascular disease in diabetes: a double hit? (English)

1 reference

13 August 2017

1 reference

Maya S P Huijberts

1

1 reference

13 August 2017

Annemarie Becker

series ordinal

2

1 reference

13 August 2017

Coen D A Stehouwer

series ordinal

3

1 reference

13 August 2017

language of work or name

1 reference

1 January 2005

1 reference

Clinical Chemistry and Laboratory Medicine

13 August 2017

1 reference

13 August 2017

43

1 reference

13 August 2017

10

1 reference

13 August 2017

993-1000

1 reference

Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus.

13 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Hyperhomocysteinemia in type 2 diabetes mellitus: cardiovascular risk factors and effect of treatment with folic acid and pyridoxine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Radicals and oxidative stress in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

S-adenosylmethionine and 5-methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

No net renal extraction of homocysteine in fasting humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Homocysteine metabolism in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Increasing homocysteine levels and diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Serum homocysteine concentration is related to diabetes mellitus, but not to coronary heart disease, in Saudi Arabians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Homocysteine and hypomethylation. A novel link to vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Plasma homocysteine concentrations in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

Hyperhomocysteinaemia is not related to risk of distal somatic polyneuropathy: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.174

21 January 2018

Identifiers

DOI

10.1515/CCLM.2005.174

1 reference

13 August 2017

1 reference